Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Cyteir Therapeutics, Inc.
Eli Lilly and Company
Actuate Therapeutics Inc.
Syros Pharmaceuticals
Gilead Sciences
University of Maryland, Baltimore
Eli Lilly and Company
Celgene
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National University Hospital, Singapore